Vaxart
VXRT
VXRT was delisted on the 7th of July, 2025.
109 hedge funds and large institutions have $25.8M invested in Vaxart in 2023 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 30 increasing their positions, 36 reducing their positions, and 29 closing their positions.
353% more call options, than puts
Call options by funds: $204K | Put options by funds: $45K
8.63% less ownership
Funds ownership: 33.76% → 25.13% (-8.6%)
17% less repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 36
17% less funds holding
Funds holding: 132 → 109 (-23)
40% less capital invested
Capital invested by funds: $42.9M → $25.8M (-$17.2M)
72% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 29
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
N
Nuveen
Charlotte,
North Carolina
|
+$1.12M |
| 2 |
State Street
Boston,
Massachusetts
|
+$237K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$202K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$97.6K |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$95.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$1.82M |
| 2 |
Millennium Management
New York
|
-$1.5M |
| 3 |
Two Sigma Investments
New York
|
-$1.34M |
| 4 |
Two Sigma Advisers
New York
|
-$889K |
| 5 |
Renaissance Technologies
New York
|
-$887K |
VXRT Hedge Fund Activity: Q1 2023 in Review
109 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Vaxart (VXRT) for Q1 2023, worth a combined $25.8M — down 40% from $42.9M a quarter earlier.
Sellers outnumbered buyers: 29 funds closed out of VXRT and 8 opened new positions — a net loss of 21 holders — while 36 trimmed existing stakes and 30 added.
The largest buyer was Nuveen, adding an estimated $1.12M. The largest seller was Citadel Advisors, cutting an estimated $1.82M.
- 109 institutional investors held Vaxart (VXRT) as of Q1 2023, down from 132 in Q4 2022.
- Funds reported $25.8M of Vaxart stock for Q1 2023, down 40% quarter-over-quarter.
- 8 funds opened new Vaxart positions in Q1 2023 and 29 closed out, a net change of -21 holders.
- The largest Vaxart buyer in Q1 2023 was Nuveen, an estimated $1.12M added.
- The largest Vaxart seller in Q1 2023 was Citadel Advisors, an estimated $1.82M sold.
Based on aggregated 13F filings for Q1 2023.